-

Eurofins Opens Europe-Wide COVID-19 Testing Centre Network to Facilitate Summer Travel

LUXEMBOURG--(BUSINESS WIRE)--Easy, reliable, high-quality and cost-effective testing for SARS-CoV-2 (COVID-19), in compliance with local regulatory requirements, is crucial to enabling millions of passengers to complete their journeys in comfort and safety. Eurofins has rapidly developed a broad network of around 500 testing centres across Europe and intends to have established around 1000 testing centres by early July.

Eurofins’ network of testing centres covers major travelling hubs and provides testing accessibility in a broad variety of locations such as supermarkets, business parks and residential areas, improving customer proximity and ease of testing.

Eurofins also operates mobile testing centres to further increase availability and access. Such mobile facilities can be used by municipal authorities to reduce pressure on existing testing centres by quickly adding sampling capacity. These mobile collection centres can each process up to 200 PCR tests per day. Eurofins has already launched this service in Belgium, France and Germany.

Additionally, to further support testing, in particular for European travel this summer, Eurofins has created an intuitive web-portal for travelers to book testing appointments and access their testing information, not only in their country of origin, but also at destination locations. All of Eurofins’ testing centres are listed on a single landing page, identifying nearby testing locations. This portal is available in 12 languages; https://www.eurofins.com/covid19-travel-regulations-testing-stations/

Eurofins is committed to offering the best possible testing services to all travellers looking for a seamless, comfortable and safe travel experience. Eurofins has also invested in laboratory capacity and IT solutions that will ensure fast turn-around times for test results (as low as a few hours from receipt of sample at the laboratory for gold standard PCR Tests). Alongside Eurofins’ home-testing offering (where supported by Health Authorities), the Group’s extensive testing centres and mobile sample facilities enable Eurofins to offer an easy and comprehensive experience for international travellers across Europe and the world.

For more information, please visit https://www.eurofins.com/eurofins-safer-work-covid-19-solutions/.

Notes to editor:

About Eurofins – the global leader in bio-analysis

Eurofins is Testing for Life. With over 50,000 staff across a network of more than 800 laboratories in over 50 countries, Eurofins’ companies offer a portfolio of over 200,000 analytical methods.

Eurofins Shares are listed on Euronext Paris Stock Exchange.

Contacts

Javier Sanchez Saura
Investor Relations
Eurofins Scientific SE
E-mail: ir@eurofins.com

Eurofins Scientific SE

BOURSE:ERF

Release Versions

Contacts

Javier Sanchez Saura
Investor Relations
Eurofins Scientific SE
E-mail: ir@eurofins.com

More News From Eurofins Scientific SE

Eurofins Scientific SE: Weekly Report on Share Repurchases From 11th May to 15th May 2026

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFC   529900JEHFM47DYY3S57   11/05/2026   FR0014000MR3   15 000   58.4581   CEUX EUROFINS SCIENTIFC   529900JEHFM47DYY3S57   11/05/2026   FR0014000MR3   45 000   58.4506   XPAR EUROFINS...

Eurofins Companies Across the World Develop New Solutions to Support Health Authorities Monitoring the Hantavirus Outbreak

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF) companies are actively monitoring the hantavirus outbreak, and developments related to the Andes strain. As of 12 May, a total of 11 hantavirus cases, including 3 deaths, associated with a cruise ship outbreak had been reported. While the World Health Organization has stated that more cases of the virus are expected it has also indicated that “there is no sign that we are seeing the start of a larger outbreak”.1 Eurofins compani...

Eurofins Scientific SE: Weekly Report on Share Repurchases From 04th May to 08th May 2026

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFC 529900JEHFM47DYY3S57 04/05/2026 FR0014000MR3 45 000 57.9715 XPAR EUROFINS SCIENTIFC 529900JEHFM47DYY3S57 04/05/2026 FR0014000MR3 15 000 57.9946 CEUX EUROFINS SCIENTIFC 529900JEHFM47D...
Back to Newsroom